Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 2900193)

Published in Liver Transpl on June 01, 2008

Authors

Andrea DiMartini1, Paulo Fontes, Mary Amanda Dew, Francis E Lotrich, Michael de Vera

Author Affiliations

1: Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. dimartiniaf@upmc.edu

Articles cited by this

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke (2003) 3.58

Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int (2000) 2.43

Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci (2006) 1.70

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol (2003) 1.33

Drug therapy in the elderly. Exp Gerontol (2004) 1.26

FK506-induced neurotoxicity in liver transplantation. Ann Neurol (1994) 1.16

Age-related changes in the blood-brain barrier. Exp Gerontol (1997) 1.09

Normal brain ageing: models and mechanisms. Philos Trans R Soc Lond B Biol Sci (2005) 1.04

Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. J Hepatol (1994) 1.00

A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl (2003) 1.00

Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation (1994) 0.95

FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. Transplant Proc (2002) 0.86

Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. Transplantation (2000) 0.84

Psychiatric morbidity in liver transplant patients. Transplant Proc (1991) 0.80

Tacrolimus (FK506)-induced mutism after liver transplant. Pediatr Neurol (2003) 0.79

Back to the future. Transplantation (2005) 0.79

Prospective study of FK506 side effects: anxiety or akathisia? Biol Psychiatry (1996) 0.79

Articles by these authors

Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 3.24

The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17

Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA (2009) 2.60

Procuring organ donors as a health investment: how much should we be willing to spend? Transplantation (2004) 2.47

Masquerader: high mobility group box-1 and cancer. Clin Cancer Res (2007) 2.40

Prevalence of behavioral symptoms: comparison of the minimum data set assessments with research instruments. J Am Med Dir Assoc (2008) 2.25

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23

Muscle mass predicts outcomes following liver transplantation. Liver Transpl (2013) 2.04

Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02

Role of baseline echocardiography in the preoperative management of liver transplant candidates. Am J Cardiol (2012) 1.98

User-centered design and interactive health technologies for patients. Comput Inform Nurs (2009) 1.93

Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.89

Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression. J Am Geriatr Soc (2007) 1.85

Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS (2004) 1.84

Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg (2009) 1.82

Patient suffering and caregiver compassion: new opportunities for research, practice, and policy. Gerontologist (2007) 1.77

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry (2005) 1.76

The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med (2006) 1.75

Race and ethnicity in decisions about unrelated hematopoietic stem cell donation. Blood (2012) 1.73

Effect of rehabilitation site on functional recovery after hip fracture. Arch Phys Med Rehabil (2005) 1.69

Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry (2007) 1.67

Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc (2014) 1.65

Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl (2011) 1.63

Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry (2003) 1.60

Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry (2007) 1.60

Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl (2005) 1.55

Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54

Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Int J Geriatr Psychiatry (2004) 1.51

Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51

Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant (2010) 1.51

Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc (2007) 1.50

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry (2011) 1.48

Monitoring alcohol use on the liver transplant wait list: therapeutic and practical issues. Liver Transpl (2012) 1.45

The Pittsburgh Rehabilitation Participation Scale: reliability and validity of a clinician-rated measure of participation in acute rehabilitation. Arch Phys Med Rehabil (2004) 1.44

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43

Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter-defibrillators. Heart Rhythm (2013) 1.43

The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry (2009) 1.41

Somatic symptoms of depression in elderly patients with medical comorbidities. Int J Geriatr Psychiatry (2005) 1.39

MELD and prediction of post-liver transplantation survival. Liver Transpl (2006) 1.33

Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun (2009) 1.31

Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg (2009) 1.30

Intelligent assistive technology applications to dementia care: current capabilities, limitations, and future challenges. Am J Geriatr Psychiatry (2009) 1.26

Social inequalities in response to antidepressant treatment in older adults. Arch Gen Psychiatry (2006) 1.25

Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clin Transplant (2009) 1.24

Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24

Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment. Int J Geriatr Psychiatry (2005) 1.24

Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol (2006) 1.23

Building PROMIS item banks: librarians as co-investigators. Qual Life Res (2009) 1.22

Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology (2004) 1.21

Mature rapid response system and potentially avoidable cardiopulmonary arrests in hospital. Qual Saf Health Care (2007) 1.21

Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med (2004) 1.20

Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Am J Geriatr Psychiatry (2007) 1.19

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol (2008) 1.18

Individual quality of life in chronic kidney disease: influence of age and dialysis modality. Clin J Am Soc Nephrol (2009) 1.18

Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging (2004) 1.18

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16

Early intervention to reduce the global health and economic burden of major depression in older adults. Annu Rev Public Health (2012) 1.15

What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? J Clin Psychopharmacol (2006) 1.14

Cognitive and affective predictors of rehabilitation participation after stroke. Arch Phys Med Rehabil (2010) 1.12

Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors. Transplantation (2003) 1.12

Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol (2006) 1.12

Psychiatric aspects of organ transplantation in critical care. Crit Care Clin (2008) 1.11

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl (2009) 1.10

Incomplete response in late-life depression: getting to remission. Dialogues Clin Neurosci (2008) 1.10

Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age. J Affect Disord (2006) 1.09

Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J Hepatol (2008) 1.08

Trajectories of treatment response in late-life depression: psychosocial and clinical correlates. J Clin Psychopharmacol (2005) 1.07

The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc (2008) 1.05

Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology (2007) 1.04

Comparisons of methods for multiple hypothesis testing in neuropsychological research. Neuropsychology (2009) 1.04

Gene-environment interactions and depression. JAMA (2009) 1.04

Impact of fatigue on outcomes in the hemodialysis (HEMO) study. Am J Nephrol (2011) 1.03

Comorbid anxiety disorder in late life depression: association with memory decline over four years. Int J Geriatr Psychiatry (2005) 1.03

Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry (2005) 1.03

Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry (2004) 1.03

Attrition of potential bone marrow donors at two key decision points leading to donation. Transplantation (2004) 1.03

Avoidant coping with health problems is related to poorer quality of life among lung transplant candidates. Prog Transplant (2003) 1.02

Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship? Am J Geriatr Psychiatry (2004) 1.02

Significance of poor patient participation in physical and occupational therapy for functional outcome and length of stay. Arch Phys Med Rehabil (2004) 1.01

Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment. Am J Psychiatry (2002) 1.01

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry (2007) 1.01

Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management. Int J Geriatr Psychiatry (2010) 1.01

Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. Psychiatry Res (2010) 1.01

Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. J Clin Psychiatry (2009) 1.00

Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transplant (2010) 0.99

Developing complex interventions: lessons learned from a pilot study examining strategy training in acute stroke rehabilitation. Clin Rehabil (2013) 0.98

One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up. Transplantation (2011) 0.97

Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. Am J Geriatr Psychiatry (2002) 0.97

Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation (2013) 0.96

Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects. J Clin Pharmacol (2004) 0.96

Good treatment outcomes in late-life depression with comorbid anxiety. J Affect Disord (2003) 0.96

Numeracy skills in CKD: correlates and outcomes. Clin J Am Soc Nephrol (2010) 0.95

Early intervention to preempt major depression among older black and white adults. Psychiatr Serv (2014) 0.95

Body pain and treatment response in late-life depression. Am J Geriatr Psychiatry (2005) 0.95